Skip to main content
OpenTrials
Completed

NCT Number: NCT04959955

Project to Improve the Diagnosis and Treatment Ability of Adult Severe Community Acquired Lower Respiratory Tract Infection

1. Objective to understand the proportion of atypical pathogens in the pathogens of SCAP and AECOPD in urban hospitals in China. 2. Objective to investigate the antimicrobial resistance of atypical pathogens in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) and SCAP in urban hospitals. 3. Objective to master the important clinical characteristics of patients with acute exacerbation of SCAP and COPD caused by atypical pathogens and mixed infection in urban hospitals in China, and to put forward the experience judgment index. 4. Objective to evaluate the advantages of various diagnostic methods for atypical pathogens causing lower respiratory tract infection. 5. It is suggested that the current empirical treatment of SCAP and severe COPD in China should be improved.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cap COPD Exacerbation

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • SCAP
  • AECOPD

Exclusion criteria

  • Pregnant or lactating women.
  • Patients with bronchiectasis.
  • Patients with active pulmonary tuberculosis.
  • Aspiration pneumonia or obstructive pneumonia.
  • Two weeks before the onset of hospital treatment history, this infection can not be excluded from hospital acquired infection.
  • HIV positive patients (but HIV testing is not required).
  • Patients who are unable and / or unable to understand and / or implement the investigation protocol.

Treatment and study plan

Primary outcomes

  1. Incidence of atypical pathogens and mixed infections

    Time frame: 2year Incidence

    Incidence of atypical pathogens and mixed infections

Sponsors and collaborators

Lead sponsor

Peking University Third Hospital

Other

Collaborators

  • First Hospital of China Medical University

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2019
First posted
Jul 13, 2021
Registry last updated
Jul 13, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.